A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.
Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, Hundley JE, Koester SK, Troyer DA, Bearss DJ, Conner MW, Gibbs JB, Hamilton K, Koblan KS, Mosser SD, O'Neill TJ, Schaber MD, Senderak ET, Windle JJ, Oliff A, Kohl NE.
Barrington RE, et al. Among authors: windle jj.
Mol Cell Biol. 1998 Jan;18(1):85-92. doi: 10.1128/MCB.18.1.85.
Mol Cell Biol. 1998.
PMID: 9418856
Free PMC article.